Cargando…

Evaluation of false positives in the SARS-CoV-2 quantitative antigen test

INTRODUCTION: Highly sensitive reagents for detecting SARS-CoV-2 antigens have been developed for accurate and rapid diagnosis till date. In this study, we aim to clarify the frequency of false-positive reactions and reveal their details in SARS-CoV-2 quantitative antigen test using an automated lab...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Ryo, Murai, Ryosei, Moriai, Mikako, Nirasawa, Shinya, Yonezawa, Hitoshi, Kondoh, Takashi, Saeki, Masachika, Yakuwa, Yuki, Sato, Yuki, Katayama, Yuki, Nakafuri, Hirotaka, Kitayama, Ikumi, Asanuma, Koichi, Fujiya, Yoshihiro, Takahashi, Satoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226058/
https://www.ncbi.nlm.nih.gov/pubmed/34238663
http://dx.doi.org/10.1016/j.jiac.2021.06.019
_version_ 1783712204003999744
author Kobayashi, Ryo
Murai, Ryosei
Moriai, Mikako
Nirasawa, Shinya
Yonezawa, Hitoshi
Kondoh, Takashi
Saeki, Masachika
Yakuwa, Yuki
Sato, Yuki
Katayama, Yuki
Nakafuri, Hirotaka
Kitayama, Ikumi
Asanuma, Koichi
Fujiya, Yoshihiro
Takahashi, Satoshi
author_facet Kobayashi, Ryo
Murai, Ryosei
Moriai, Mikako
Nirasawa, Shinya
Yonezawa, Hitoshi
Kondoh, Takashi
Saeki, Masachika
Yakuwa, Yuki
Sato, Yuki
Katayama, Yuki
Nakafuri, Hirotaka
Kitayama, Ikumi
Asanuma, Koichi
Fujiya, Yoshihiro
Takahashi, Satoshi
author_sort Kobayashi, Ryo
collection PubMed
description INTRODUCTION: Highly sensitive reagents for detecting SARS-CoV-2 antigens have been developed for accurate and rapid diagnosis till date. In this study, we aim to clarify the frequency of false-positive reactions and reveal their details in SARS-CoV-2 quantitative antigen test using an automated laboratory device. METHODS: Nasopharyngeal swab samples (n = 4992) and saliva samples (n = 5430) were collected. We measured their SARS-CoV-2 antigen using Lumipulse® Presto SARS-CoV-2 Ag and performed a nucleic acid amplification test (NAAT) using the Ampdirect™ 2019 Novel Coronavirus Detection Kit as needed. The results obtained from each detection test were compared accordingly. RESULTS: There were 304 nasopharyngeal samples and 114 saliva samples were positive in the Lumipulse® Presto SARS-CoV-2 Ag test. All positive nasopharyngeal samples in the antigen test were also positive for NAAT. In contrast, only three (2.6%) of all the positive saliva samples in the antigen test were negative for NAAT. One showed no linearity with a dilute solution in the dilution test. Additionally, the quantitative antigen levels of all the three samples did not decrease after reaction with the anti-SARS-CoV-2 antibody. CONCLUSIONS: The judgment difference between the quantitative antigen test and NAAT seemed to be caused by non-specific reactions in the antigen test. Although the high positive and negative predictive value of this quantitative antigen test could be confirmed, we should consider the possibility of false-positives caused by non-specific reactions and understand the characteristics of antigen testing. We recommend that repeating centrifugation before measurement, especially in saliva samples, should be performed appropriately.
format Online
Article
Text
id pubmed-8226058
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-82260582021-06-25 Evaluation of false positives in the SARS-CoV-2 quantitative antigen test Kobayashi, Ryo Murai, Ryosei Moriai, Mikako Nirasawa, Shinya Yonezawa, Hitoshi Kondoh, Takashi Saeki, Masachika Yakuwa, Yuki Sato, Yuki Katayama, Yuki Nakafuri, Hirotaka Kitayama, Ikumi Asanuma, Koichi Fujiya, Yoshihiro Takahashi, Satoshi J Infect Chemother Original Article INTRODUCTION: Highly sensitive reagents for detecting SARS-CoV-2 antigens have been developed for accurate and rapid diagnosis till date. In this study, we aim to clarify the frequency of false-positive reactions and reveal their details in SARS-CoV-2 quantitative antigen test using an automated laboratory device. METHODS: Nasopharyngeal swab samples (n = 4992) and saliva samples (n = 5430) were collected. We measured their SARS-CoV-2 antigen using Lumipulse® Presto SARS-CoV-2 Ag and performed a nucleic acid amplification test (NAAT) using the Ampdirect™ 2019 Novel Coronavirus Detection Kit as needed. The results obtained from each detection test were compared accordingly. RESULTS: There were 304 nasopharyngeal samples and 114 saliva samples were positive in the Lumipulse® Presto SARS-CoV-2 Ag test. All positive nasopharyngeal samples in the antigen test were also positive for NAAT. In contrast, only three (2.6%) of all the positive saliva samples in the antigen test were negative for NAAT. One showed no linearity with a dilute solution in the dilution test. Additionally, the quantitative antigen levels of all the three samples did not decrease after reaction with the anti-SARS-CoV-2 antibody. CONCLUSIONS: The judgment difference between the quantitative antigen test and NAAT seemed to be caused by non-specific reactions in the antigen test. Although the high positive and negative predictive value of this quantitative antigen test could be confirmed, we should consider the possibility of false-positives caused by non-specific reactions and understand the characteristics of antigen testing. We recommend that repeating centrifugation before measurement, especially in saliva samples, should be performed appropriately. Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2021-10 2021-06-25 /pmc/articles/PMC8226058/ /pubmed/34238663 http://dx.doi.org/10.1016/j.jiac.2021.06.019 Text en © 2021 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Original Article
Kobayashi, Ryo
Murai, Ryosei
Moriai, Mikako
Nirasawa, Shinya
Yonezawa, Hitoshi
Kondoh, Takashi
Saeki, Masachika
Yakuwa, Yuki
Sato, Yuki
Katayama, Yuki
Nakafuri, Hirotaka
Kitayama, Ikumi
Asanuma, Koichi
Fujiya, Yoshihiro
Takahashi, Satoshi
Evaluation of false positives in the SARS-CoV-2 quantitative antigen test
title Evaluation of false positives in the SARS-CoV-2 quantitative antigen test
title_full Evaluation of false positives in the SARS-CoV-2 quantitative antigen test
title_fullStr Evaluation of false positives in the SARS-CoV-2 quantitative antigen test
title_full_unstemmed Evaluation of false positives in the SARS-CoV-2 quantitative antigen test
title_short Evaluation of false positives in the SARS-CoV-2 quantitative antigen test
title_sort evaluation of false positives in the sars-cov-2 quantitative antigen test
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226058/
https://www.ncbi.nlm.nih.gov/pubmed/34238663
http://dx.doi.org/10.1016/j.jiac.2021.06.019
work_keys_str_mv AT kobayashiryo evaluationoffalsepositivesinthesarscov2quantitativeantigentest
AT murairyosei evaluationoffalsepositivesinthesarscov2quantitativeantigentest
AT moriaimikako evaluationoffalsepositivesinthesarscov2quantitativeantigentest
AT nirasawashinya evaluationoffalsepositivesinthesarscov2quantitativeantigentest
AT yonezawahitoshi evaluationoffalsepositivesinthesarscov2quantitativeantigentest
AT kondohtakashi evaluationoffalsepositivesinthesarscov2quantitativeantigentest
AT saekimasachika evaluationoffalsepositivesinthesarscov2quantitativeantigentest
AT yakuwayuki evaluationoffalsepositivesinthesarscov2quantitativeantigentest
AT satoyuki evaluationoffalsepositivesinthesarscov2quantitativeantigentest
AT katayamayuki evaluationoffalsepositivesinthesarscov2quantitativeantigentest
AT nakafurihirotaka evaluationoffalsepositivesinthesarscov2quantitativeantigentest
AT kitayamaikumi evaluationoffalsepositivesinthesarscov2quantitativeantigentest
AT asanumakoichi evaluationoffalsepositivesinthesarscov2quantitativeantigentest
AT fujiyayoshihiro evaluationoffalsepositivesinthesarscov2quantitativeantigentest
AT takahashisatoshi evaluationoffalsepositivesinthesarscov2quantitativeantigentest